Jong-Hyeon Jeong Department of Biostatistics University of Pittsburgh Biography Publications Institution JoVE Articles Jong-Hyeon Jeong has not added a biography. If you are Jong-Hyeon Jeong and would like to personalize this page please email our Author Liaison for assistance. Publications Stationary Versus Agitated Storage of Whole Blood During Acute Normovolemic Hemodilution Anesthesia and Analgesia. Feb, 2014 | Pubmed ID: 24445627 Predicting Degree of Benefit from Adjuvant Trastuzumab in NSABP Trial B-31 Journal of the National Cancer Institute. Dec, 2013 | Pubmed ID: 24262440 An Isoform of C/EBPβ, LIP, Regulates Expression of the Chemokine Receptor CXCR4 and Modulates Breast Cancer Cell Migration The Journal of Biological Chemistry. Oct, 2013 | Pubmed ID: 23966000 Reply to V. Pitini Et Al Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2013 | Pubmed ID: 23901419 Constrained Parametric Model for Simultaneous Inference of Two Cumulative Incidence Functions Biometrical Journal. Biometrische Zeitschrift. Jan, 2013 | Pubmed ID: 23090878 Nonparametric Inference on Cause-specific Quantile Residual Life Biometrical Journal. Biometrische Zeitschrift. Jan, 2013 | Pubmed ID: 23065930 Median Tests for Censored Survival Data; a Contingency Table Approach Biometrics. Sep, 2012 | Pubmed ID: 23189327 Seven-year Follow-up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) with ACP Plus Trastuzumab As Adjuvant Therapy for Patients with Node-positive, Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2012 | Pubmed ID: 22987084 Reporting of Cause-specific Treatment Effects in Cancer Clinical Trials with Competing Risks: a Systematic Review Contemporary Clinical Trials. Sep, 2012 | Pubmed ID: 22664646 Bayesian Nonparametric Inference on Quantile Residual Life Function: Application to Breast Cancer Data Statistics in Medicine. Aug, 2012 | Pubmed ID: 22437758 Censored Quantile Regression for Residual Lifetimes Lifetime Data Analysis. Apr, 2012 | Pubmed ID: 22183141 Population-based Study of Competing Mortality in Head and Neck Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Sep, 2011 | Pubmed ID: 21844503 Four-year Follow-up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-positive Breast Cancer: Joint Analysis of Data from NCCTG N9831 and NSABP B-31 Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Sep, 2011 | Pubmed ID: 21768458 Evaluation of Spontaneous Propulsive Movement As a Screening Tool to Detect Rescue of Parkinsonism Phenotypes in Zebrafish Models Neurobiology of Disease. Oct, 2011 | Pubmed ID: 21669287 Breast Cancer Adjuvant Therapy: Time to Consider Its Time-dependent Effects Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2011 | Pubmed ID: 21555693 Empirical Likelihood Ratio Test for Median and Mean Residual Lifetime Statistics in Medicine. Jan, 2011 | Pubmed ID: 21204121 Amenorrhea from Breast Cancer Therapy--not a Matter of Dose The New England Journal of Medicine. Dec, 2010 | Pubmed ID: 21121855 Predictors of Competing Mortality in Early Breast Cancer Cancer. Dec, 2010 | Pubmed ID: 20737562 Pitfalls of Using Composite Primary End Points in the Presence of Competing Risks Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2010 | Pubmed ID: 20713860 Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer The New England Journal of Medicine. Jun, 2010 | Pubmed ID: 20519679 Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-positive Breast Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2010 | Pubmed ID: 20479407 Evaluation of Microtubule-associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Sep, 2009 | Pubmed ID: 19667268 Regression on Quantile Residual Life Biometrics. Dec, 2009 | Pubmed ID: 19432781 A New Generalization of Weibull Distribution with Application to a Breast Cancer Data Set Statistics in Medicine. Jul, 2009 | Pubmed ID: 19424958 Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-negative Breast Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2009 | Pubmed ID: 19349544 Statistical Analysis in Cancer Clinical Trials Anti-cancer Drugs. Feb, 2008 | Pubmed ID: 18340243 Benefit from Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-treat Analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 Trial Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2008 | Pubmed ID: 18332472 Nonparametric Inference on Median Residual Life Function Biometrics. Mar, 2008 | Pubmed ID: 17501936 Overexpression of GLUT-1 is Associated with Resistance to Radiotherapy and Adverse Prognosis in Squamous Cell Carcinoma of the Oral Cavity Oral Oncology. Sep, 2007 | Pubmed ID: 17207657 Parametric Regression on Cumulative Incidence Function Biostatistics (Oxford, England). Apr, 2007 | Pubmed ID: 16636138 NSABP B-42: a Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-free Survival in Postmenopausal Women with Hormone Receptor-positive Breast Cancer Clinical Breast Cancer. Dec, 2006 | Pubmed ID: 17239269 Low Locoregional Recurrence Rate Among Node-negative Breast Cancer Patients with Tumors 5 Cm or Larger Treated by Mastectomy, with or Without Adjuvant Systemic Therapy and Without Radiotherapy: Results from Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2006 | Pubmed ID: 16921044 Application of Smoothing Methods to Evaluate Treatment-prognostic Factor Interactions in Breast Cancer Data Cancer Investigation. Apr-May, 2006 | Pubmed ID: 16809157 Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-positive Adjuvant Breast Cancer Trials Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2006 | Pubmed ID: 16648502 Clinical and Prognostic Value of [(18)F]FDG-PET for Surveillance of Oral Squamous Cell Carcinoma After Surgical Salvage Therapy Oral Oncology. Mar, 2006 | Pubmed ID: 16316775 Rank Tests for Clustered Survival Data when Dependent Subunits Are Randomized Statistics in Medicine. Feb, 2006 | Pubmed ID: 16158408 Treatment of Axillary Lymph Node-negative, Estrogen Receptor-negative Breast Cancer: Updated Findings from National Surgical Adjuvant Breast and Bowel Project Clinical Trials Journal of the National Cancer Institute. Dec, 2004 | Pubmed ID: 15601638 Patterns of Locoregional Failure in Patients with Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy with or Without Tamoxifen and Without Radiotherapy: Results from Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2004 | Pubmed ID: 15452182 Treatment of Lymph-node-negative, Oestrogen-receptor-positive Breast Cancer: Long-term Findings from National Surgical Adjuvant Breast and Bowel Project Randomised Clinical Trials Lancet. Sep 4-10, 2004 | Pubmed ID: 15351193 Detection of Recurrent Oral Squamous Cell Carcinoma by [18F]-2-fluorodeoxyglucose-positron Emission Tomography: Implications for Prognosis and Patient Management Cancer. Nov, 2003 | Pubmed ID: 14601097 Rank Tests for Clustered Survival Data Lifetime Data Analysis. Mar, 2003 | Pubmed ID: 12602772 Overexpression of Glut-1 and Increased Glucose Metabolism in Tumors Are Associated with a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma Cancer. Feb, 2003 | Pubmed ID: 12569601 A Parametric Model for Long-term Follow-up Data from Phase III Breast Cancer Clinical Trials Statistics in Medicine. Feb, 2003 | Pubmed ID: 12529867 Twenty-year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer The New England Journal of Medicine. Oct, 2002 | Pubmed ID: 12393820 Twenty-five-year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation The New England Journal of Medicine. Aug, 2002 | Pubmed ID: 12192016 A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision Amy Catherine Nau1, Christine Pintar1, Christopher Fisher1, Jong-Hyeon Jeong2, KwonHo Jeong2 1UPMC Eye Center, University of Pittsburgh, 2Department of Biostatistics, University of Pittsburgh JoVE 51205 Medicine
A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision Amy Catherine Nau1, Christine Pintar1, Christopher Fisher1, Jong-Hyeon Jeong2, KwonHo Jeong2 1UPMC Eye Center, University of Pittsburgh, 2Department of Biostatistics, University of Pittsburgh JoVE 51205 Medicine
